Liberty One Investment Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Liberty One Investment Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 03, 2020	SELL	$39.09 - $53.44 $12,860 - $17,581	-329 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$46.7 - $92.04 $15,364 - $30,281	329 New	329 $16,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty One Investment Management, LLC with notifications on news.